Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LiveSpo Smile CARE probiotic spray in periodontal disease
NCT07258303Recruiting
- Sponsor
- AnaBio Technologies
- Start
- Dec 2025
- Primary completion
- Oct 2026
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, double-blind trial of LiveSpo Smile CARE in periodontal disease (2 arms), sponsored by AnaBio Technologies. Primary endpoints: Debris Index-Simplified at 42 days, Gingival Index at 42 days and 5 more. Started Dec 2025; status: recruiting.
02
Drugs
LiveSpo Smile CARE
03
Conditions
periodontal disease
Beyond the preview
Go deeper on NCT07258303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07258303.